Duoning Biotech and Branca Bunus to Develop Transfection Reagents
Under this agreement, the two companies will collaborate on the development, optimization, and application of transfection reagents, with the goal of providing biopharmaceutical customers with innovative transfection reagents through resource sharing, thereby enhancing the efficiency of biopharmaceutical development in upstream bioprocess.
Transfection Reagents | 07/11/2024 | By Aishwarya
Merck Signs Definitive Deal to Acquire Mirus Bio for USD 600 Million
Merck has signed a definitive agreement to acquire Mirus Bio for USD 600 million.
Transfection Reagents | 27/05/2024 | By Aishwarya | 149
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy